Capital International Investors’s Kite Pharma, Inc. KITE Stock Holding History

Capital International Investors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-198,700	Closed	-$35.7M	–	244
2017 Q3	$35.7M	Sell	198,700 -1,115,500	-85%	-$155M	0.04%	211
2017 Q2	$136M	Hold	1,314,200	–	–	0.18%	140
2017 Q1	$103M	Hold	1,314,200	–	–	0.14%	154
2016 Q4	$58.9M	Hold	1,314,200	–	–	0.09%	178
2016 Q3	$73.4M	Buy	1,314,200 +589,500	+81%	+$32.8M	0.11%	175
2016 Q2	$36.2M	Hold	724,700	–	–	0.05%	209
2016 Q1	$33.3M	Hold	724,700	–	–	0.05%	215
2015 Q4	$44.7M	Hold	724,700	–	–	0.07%	208
2015 Q3	$40.4M	Hold	724,700	–	–	0.07%	200
2015 Q2	$44.2M	Hold	724,700	–	–	0.07%	197
2015 Q1	$41.8M	Hold	724,700	–	–	0.08%	197
2014 Q4	$41.8M	Buy	+724,700	New	+$30.5M	0.09%	188

Capital International Investors's KITE Position: Q4 2017 in Review

Capital International Investors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 198,700 shares — an estimated $35.7M sold.

Capital International Investors first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $136M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Capital International Investors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Capital International Investors sold 198,700 Kite Pharma, Inc. shares in Q4 2017, an estimated $35.7M.
Capital International Investors first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
Capital International Investors's Kite Pharma, Inc. position peaked at $136M in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Capital International Investors's 13F filing for Q4 2017, filed 14 Feb 2018.